SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: David Howe who wrote (3300)6/16/1999 2:31:00 PM
From: j_fir2  Read Replies (1) | Respond to of 10280
 
My mistake, so sorry:
"The drug is unique because it is designed to treat the origins of epilepsy, rather than its symptoms, says Caroline Lauwers, an analyst with KBC Securities in Brussels. UCB claims it reduces the frequency of sufferers' seizures."

I take it they don't know the origins of epilepsy either.

j'fir